Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Scott B. Reeder
University of Wisconsin Madison, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Neuwave Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This outside activity has a nexus with the investigator's research activities because the outside activity arises from and relies upon the academic expertise that qualifies this individual to participate in this PHS funded research activity.
The combination of the investigator's significant financial interest in the outside activity and the nexus between the investigator's research corresponds to the definition of a FCOI and so requires management.
Confounder-Corrected Quantitative MRI Biomarkers of Hepatic
The overall goal of this research is to validate a new, rapid, and non-invasive method to measure iron concentration in the liver with magnetic resonance imaging (MRI). Toxic levels of iron can accumulate in the liver due to many conditions such as certain hereditary diseases and in patients who receive a large number of blood transfusions. We will test the performance of the new method in patients at four different institutions, in order to translate it into widespread clinical practice and provide physicians with a validated method for diagnosis and treatment monitoring of iron overload.
Filed on June 09, 2014.
Tell us what you know about Scott B. Reeder's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Scott B. Reeder filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Elucent | $80,000 - $99,999 |
Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Elucent | $80,000 - $99,999 |
Scott B. Reeder | University of Wisconsin Madison | Conflict of Interest | Neuwave Inc. | $20,000 - $39,999 |
Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Reveal Pharmaceuticals | $20,000 - $39,999 |
Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Reveal Pharmaceuticals | $20,000 - $39,999 |
Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Calimetrix | $0 - $4,999 |
Scott Reeder | University of Wisconsin Madison | Conflict of Interest | Calimetrix | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.